MAP1LC3A and colorectal carcinoma: Additionally, the number of LC3 puncta, as well as the levels of autophagic markers, were also increased by the combined treatment of DHA and Oxaliplatin in other CRC cells, as well as in DLD-1 and SW620 cells (Figure S2B,D), suggesting that autophagy was increased, which indicated its involvement in Oxaliplatin and DHA combination-induced cell death.